TREA

90322340 - C

Follow

Information

  • Trademark
  • 90322340
  • Serial Number
    90322340
  • Registration Number
    6454659
  • Filing Date
    November 16, 2020
    5 years ago
  • Registration Date
    August 17, 2021
    4 years ago
  • Transaction Date
    August 17, 2021
    4 years ago
  • Status Date
    August 17, 2021
    4 years ago
  • Published for Opposition Date
    June 01, 2021
    4 years ago
  • Location Date
    August 17, 2021
    4 years ago
  • First Use Anywhere Date
    December 02, 2009
    16 years ago
  • First Use In Commerce Date
    December 02, 2009
    16 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BATT, JAIME L
  • Attorney Docket Number
    U2400-00075
    Attorney Name
    Nicole K. McLaughlin
    Law Office Assigned Location Code
    N70
  • Owners
Information
Mark Drawing Code
5000
Mark Identification
C
Case File Statements
  • DM0000: The mark consists of stylized version of the letter "C".
  • GS0051: Pharmaceutical preparations and substances for the diagnosis, treatment and prevention of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; pharmaceutical preparations for the treatment and prevention of Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; Antibacterial, antiviral and antifungal preparations for skin and wound healing; disinfectants and antiseptics; antimicrobial cleansers for sanitation purposes; Medical assays for testing of bodily fluids and tissues for testing of enzymes in humans; biological preparations for medical testing; diagnostic preparations for medical purposes; testing kits comprised of medical diagnostic reagents and assays for testing enzymes and body fluids for use in disease detection; medical diagnostic reagents and assays for testing of enzymes and body fluids; chemical preparations for medical testing; diagnostic biomarker reagents for medical testing; all the foregoing for the diagnosis and treatment of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders
  • GS0421: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and pharmaceutical research; Development of pharmaceuticals and medical devices for others; Providing temporary use of non-downloadable computer software that allows users to make determinations regarding neurological diseases, specifically baseline staging, data gathering and monitoring of early, middle and late stage neurological diseases; Design and development of medical assays for others; clinical research and development of treatments for viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; clinical research and development of treatments for the treatment and prevention of Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; clinical research and development of treatments for antibacterial, antiviral, and antifungal preparations for skin and wound healing; clinical research and development of disinfectants, antiseptics and antimicrobial cleansers for sanitation purposes; medical and scientific research services in the field of digestion and detection of enzymes or biological substances in the body
  • GS0441: Medical testing for diagnostic and treatment purposes; Medical consultations; medical testing for diagnostic treatment purposes in the fields of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological and immune system related diseases and disorders; medical testing for diagnostic treatment and prevention of Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; Medical diagnostic testing, monitoring and reporting services; performing diagnosis of diseases; Health care services, namely, the administration of medical assays for the detection of enzymes in humans
Case File Event Statements
  • 8/17/2021 - 4 years ago
    13 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/1/2021 - 4 years ago
    12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/1/2021 - 4 years ago
    11 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/12/2021 - 4 years ago
    10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/3/2021 - 4 years ago
    9 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 5/3/2021 - 4 years ago
    8 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 5/3/2021 - 4 years ago
    7 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 5/3/2021 - 4 years ago
    6 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 5/3/2021 - 4 years ago
    5 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 4/27/2021 - 4 years ago
    4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/26/2021 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/15/2021 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 11/19/2020 - 5 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP